HomeHealthcare & Life SciencesBiotechnology Stargardts Treatment Market

Saudi Arabia Stargardts Treatment Market Size & Outlook, 2026-2034


Saudi Arabia Stargardts Treatment Market Insights

  • As per Reed Intelligence insights, the Saudi Arabia Stargardts Treatment Market stood at USD 53.38 Million in 2025 and is anticipated to grow to USD 139.23 Million by 2034.
  • The Saudi Arabia market is expected to advance at a CAGR of 11.15% from 2026 through 2034.
  • In 2025, Gene Therapy accounted for the highest share of the Treatment Type market size.
  • During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Treatment Type segment.

Other Key Findings


  • As of 2025, Saudi Arabia held 1.35% of the global Stargardts Treatment Market size.
  • By 2034, United States is anticipated to capture the largest share of the global Stargardts Treatment Market.
  • In Middle East and Africa, United Arab Emirates is expected to lead the regional Stargardts Treatment Market size by 2034.
  • United Arab Emirates will remain the fastest-growing market in Middle East and Africa, reaching USD 495.91 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 53.38 Million
Market Size In 2034 USD 139.23 Million
Largest segment Gene Therapy
Units Revenue in USD Million
CAGR 11.15% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Gene Therapy
  2. Stem Cell Therapy
  3. Pharmacological Therapy
  4. Nutritional and Supportive Therapy
Disease Stage
  1. Early Stage
  2. Intermediate Stage
  3. Advanced Stage
End-Use
  1. Hospitals and Ophthalmology Clinics
  2. Research Institutes
  3. Specialty Eye Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports